Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non–small cell lung cancer, and renal cell carcinoma
Titel:
Safety of pembrolizumab as adjuvant therapy in a pooled analysis of phase 3 clinical trials of melanoma, non–small cell lung cancer, and renal cell carcinoma
Auteur:
Luke, Jason J. Long, Georgina V. Robert, Caroline Carlino, Matteo S. Choueiri, Toni K. Haas, Naomi B. O’Brien, Mary Paz-Ares, Luis Peters, Solange Powles, Thomas Leiby, Melanie A. Lin, Jianxin Zhao, Yujie Krepler, Clemens Perini, Rodolfo F. Catherine Pietanza, M. Samkari, Ayman Gruber, Todd Ibrahim, Nageatte Eggermont, Alexander M.M.